TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/06/20
Earnings Preview: TherapeuticsMD (TXMD) Q1 Earnings Expected to DeclineZacks Investment Research • 04/27/20
Is the Options Market Predicting a Spike in TherapeuticsMD (TXMD) Stock?Zacks Investment Research • 03/12/20
TherapeuticsMD Reports Encouraging Q4/2019 Earnings But The Market Doesn't CareSeeking Alpha • 02/25/20
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/20/20
Earnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to DeclineZacks Investment Research • 02/13/20
TherapeuticsMD's Business Model Affirms Additional Dilution Is Practically Certain In FY2020Seeking Alpha • 01/09/20
TherapeuticsMD: Hits Upper-End Of Q3 Guidance And Establishes Momentum Into 2020Seeking Alpha • 11/12/19
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
TherapeuticsMD (TXMD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/30/19
TherapeuticsMD stock slides 6% after SEC charges company with breaking disclosure rulesMarket Watch • 08/20/19
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19